(Q36438205)

14 August 2017

1 reference

title

Pharmacogenomics and antidepressant drugs (English)

1 reference

14 August 2017

1 reference

2

Florian Holsboer

0 references

Elisabeth Binder

series ordinal

1

object named as

Elisabeth B Binder

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

38

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

82-94

1 reference

Inheritance and drug response

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The genetic basis of variability in drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Clinical applications of pharmacogenetics in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The evolution of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Venlafaxine serum levels and CYP2D6 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Does increasing dose improve efficacy in patients with poor antidepressant response: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

No Influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Sequence analysis of the serotonin transporter and associations with antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Functional genomics approaches in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Effects of the G protein beta 3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on "A splice variant of the G protein beta 3-subunit implicated in disea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Stress and the brain: from adaptation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Identification of novel direct transcriptional targets of glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Altered response to mirtazapine on gene expression profile of lymphocytes from Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

The effect of citalopram on gene expression profile of Alzheimer lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Pharmacogenetic prediction of clozapine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600551045

10.1080/07853890600551045

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference